Lista de obras - Velpandi Ayyavoo - Dominio Público Uruguay

A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes

artículo científico publicado en 2008

Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor

artículo científico publicado en 2007

Analysis of genetic heterogeneity, antigenicity, and biological characteristics of HIV-1 in a maternal transmitter and nontransmitter patient pair

artículo científico publicado en 1996

Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).

artículo científico publicado en 2006

Attenuated nef DNA vaccine construct induces cellular immune response: role in HIV-1 multiprotein vaccine.

artículo científico publicado en 2003

Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope

artículo científico publicado en 2007

CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity.

artículo científico publicado en 2014

Construction of attenuated HIV-1 accessory gene immunization cassettes

artículo científico publicado en 1998

Correction: Comparative Expression Profile of miRNA and mRNA in Primary Peripheral Blood Mononuclear Cells Infected with Human Immunodeficiency Virus (HIV-1) ⬇️

artículo científico publicado el 29 de agosto de 2012

Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86.

artículo científico publicado en 2003

DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations

artículo científico publicado en 1994

Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha.

artículo científico publicado en 2007

Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization ⬇️

artículo científico publicado el 24 de mayo de 2013

Development of genetic vaccines for pathogenic genes: construction of attenuated vif DNA immunization cassettes.

artículo científico publicado en 1997

Gene Array Studies in HIV-1 Infection ⬇️

artículo científico publicado el 1 de marzo de 2012

HIV's ticket to ride: Cytotoxic T-lymphocyte-activated dendritic cells exploited for virus intercellular transfer

artículo científico publicado en 2014

HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G 2 /M phase transition of the mammalian cell cycle ⬇️

artículo científico publicado el 31 de marzo de 1998

HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B.

artículo científico publicado en 1997

HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.

artículo científico publicado en 2001

HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism

artículo científico publicado en 2009

HIV-1 viral protein R (Vpr) as a regulator of the target cell

artículo científico publicado en 1997

Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function

artículo científico publicado en 2006

Human immunodeficiency virus (HIV-1) Vpr induced downregulation of NHE1 induces alteration in intracellular pH and loss of ERM complex in target cells

artículo científico publicado en 2007

Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo.

artículo científico publicado en 2008

Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury.

artículo científico publicado en 2018

Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions.

artículo científico publicado en 2013

Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles

artículo científico publicado en 2010

Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication

artículo científico publicado en 1991

Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients

artículo científico publicado en 2006

Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes

artículo científico publicado en 2000

In vitro and in vivo tumor growth suppression by HIV-1 Vpr.

artículo científico publicado en 1997

Inclusion of Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness in vivo resulting in CD4 cell loss and increased viral loads in rhesus macaques

artículo científico publicado en 2002

Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.

artículo científico publicado en 2008

Innate immune evasion strategies by human immunodeficiency virus type 1.

artículo científico publicado en 2013

Issues for improving multiplasmid DNA vaccines for HIV-1.

artículo científico publicado en 2002

MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts

artículo científico publicado en 2013

Molecular and functional characterization of a novel splice variant of ANKHD1 that lacks the KH domain and its role in cell survival and apoptosis

artículo científico publicado en 2005

Nanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines

artículo científico publicado en 2014

Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells.

artículo científico publicado en 2012

P17-24. Interfering overlapping epitopes contribute to the subdominance of an HLA-A2-restricted HIV Gag-specific epitope

artículo científico publicado en 2009

Reconstructing the temporal progression of HIV-1 immune response pathways

artículo científico publicado en 2016

Retracted: Comparative Expression Profile of miRNA and mRNA in Primary Peripheral Blood Mononuclear Cells Infected with Human Immunodeficiency Virus (HIV-1)

artículo científico publicado en 2011

Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture

artículo científico publicado en 2012

Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr.

artículo científico publicado en 2003

Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication

artículo científico publicado en 2004

Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch

artículo científico publicado en 2015

The role of Vpr in the regulation of HIV-1 gene expression

artículo científico publicado en 2006

Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology

artículo científico publicado en 2014

Transcriptome analyses identify key cellular factors associated with HIV-1-associated neuropathogenesis in infected men.

artículo científico publicado en 2016

Vpr-GFP virion particle identifies HIV-infected targets and preserves HIV-1Vpr function in macrophages and T-cells

artículo científico publicado en 2000

Lista de obras de Velpandi Ayyavoo

A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes

Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor

Analysis of genetic heterogeneity, antigenicity, and biological characteristics of HIV-1 in a maternal transmitter and nontransmitter patient pair

Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).

Attenuated nef DNA vaccine construct induces cellular immune response: role in HIV-1 multiprotein vaccine.

Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope

CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity.

Construction of attenuated HIV-1 accessory gene immunization cassettes

Correction: Comparative Expression Profile of miRNA and mRNA in Primary Peripheral Blood Mononuclear Cells Infected with Human Immunodeficiency Virus (HIV-1) ⬇️

Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86.

DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations

Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha.

Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization ⬇️

Development of genetic vaccines for pathogenic genes: construction of attenuated vif DNA immunization cassettes.

Gene Array Studies in HIV-1 Infection ⬇️

HIV's ticket to ride: Cytotoxic T-lymphocyte-activated dendritic cells exploited for virus intercellular transfer

HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G 2 /M phase transition of the mammalian cell cycle ⬇️

HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B.

HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.

HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism

HIV-1 viral protein R (Vpr) as a regulator of the target cell

Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function

Human immunodeficiency virus (HIV-1) Vpr induced downregulation of NHE1 induces alteration in intracellular pH and loss of ERM complex in target cells

Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo.

Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury.

Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions.

Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles

Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication

Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients

Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes

In vitro and in vivo tumor growth suppression by HIV-1 Vpr.

Inclusion of Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness in vivo resulting in CD4 cell loss and increased viral loads in rhesus macaques

Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.

Innate immune evasion strategies by human immunodeficiency virus type 1.

Issues for improving multiplasmid DNA vaccines for HIV-1.

MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts

Molecular and functional characterization of a novel splice variant of ANKHD1 that lacks the KH domain and its role in cell survival and apoptosis

Nanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines

Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells.

P17-24. Interfering overlapping epitopes contribute to the subdominance of an HLA-A2-restricted HIV Gag-specific epitope

Reconstructing the temporal progression of HIV-1 immune response pathways

Retracted: Comparative Expression Profile of miRNA and mRNA in Primary Peripheral Blood Mononuclear Cells Infected with Human Immunodeficiency Virus (HIV-1)

Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture

Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr.

Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication

Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch

The role of Vpr in the regulation of HIV-1 gene expression

Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology

Transcriptome analyses identify key cellular factors associated with HIV-1-associated neuropathogenesis in infected men.

Vpr-GFP virion particle identifies HIV-infected targets and preserves HIV-1Vpr function in macrophages and T-cells